| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CorMedix Inc (NASDAQ: CRMD)
CRMD Technical Analysis
4
| As on 9th Jun 2023 CRMD STOCK Price closed @ 5.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.04 & Strong Buy for SHORT-TERM with Stoploss of 4.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRMDSTOCK Price
| Open | 5.19 | Change | Price | % |
| High | 5.21 | 1 Day | -0.03 | -0.58 |
| Low | 5.10 | 1 Week | 0.26 | 5.32 |
| Close | 5.15 | 1 Month | 0.47 | 10.04 |
| Volume | 189600 | 1 Year | 0.41 | 8.65 |
| 52 Week High 7.52 | 52 Week Low 2.73 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRMD Daily Charts |
CRMD Intraday Charts |
Whats New @ Bazaartrend |
CRMD Free Analysis |
|
|
CRMD Important Levels Intraday
| RESISTANCE | 5.36 |
| RESISTANCE | 5.29 |
| RESISTANCE | 5.25 |
| RESISTANCE | 5.21 |
| SUPPORT | 5.09 |
| SUPPORT | 5.05 |
| SUPPORT | 5.01 |
| SUPPORT | 4.94 |
CRMD Forecast April 2024
| 4th UP Forecast | 7.6 |
| 3rd UP Forecast | 6.81 |
| 2nd UP Forecast | 6.33 |
| 1st UP Forecast | 5.84 |
| 1st DOWN Forecast | 4.46 |
| 2nd DOWN Forecast | 3.97 |
| 3rd DOWN Forecast | 3.49 |
| 4th DOWN Forecast | 2.7 |
CRMD Weekly Forecast
| 4th UP Forecast | 6.56 |
| 3rd UP Forecast | 6.11 |
| 2nd UP Forecast | 5.83 |
| 1st UP Forecast | 5.55 |
| 1st DOWN Forecast | 4.75 |
| 2nd DOWN Forecast | 4.47 |
| 3rd DOWN Forecast | 4.19 |
| 4th DOWN Forecast | 3.74 |
CRMD Forecast2024
| 4th UP Forecast | 15.52 |
| 3rd UP Forecast | 12.19 |
| 2nd UP Forecast | 10.14 |
| 1st UP Forecast | 8.08 |
| 1st DOWN Forecast | 2.22 |
| 2nd DOWN Forecast | 0.16 |
| 3rd DOWN Forecast | -1.89 |
| 4th DOWN Forecast | -5.22 |
CorMedix Inc ( NASDAQ USA Symbol : CRMD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRMD Business Profile
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service